Early is Good logo — Ultra-Sensitive Multi-Omics Biomarker Detection To Transform...

Early is Good

Ultra-Sensitive Multi-Omics Biomarker Detection To Transform The Future Healthcare

Founded 2021 United States Indianapolis, United States 5 employees Seed Total: $5.50M Health Care

General Information

Company Name Early is Good
Founded Year 2021
Location United States Indianapolis, United States +1
Founders / Decision Makers
Team member
Employees 5
Industries Health Care
Funding Stage Seed
Social

Get notified when Early is Good moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Early is Good

Early is Good is a health care startup with a mission to revolutionize the future of healthcare through ultra-sensitive multi-omics biomarker detection. The company's Multi-omic Integration Platform offers a breakthrough approach by combining the detection of DNA, RNA, protein, and metabolite targets into a single assay, with a focus on early disease detection. Founded in 2020 and headquartered in the United States, Early is Good recently secured a significant $1.50M Debt Financing investment on 02 November 2022. With its cutting-edge technology and potential to transform molecular diagnostics, Early is Good presents an exciting opportunity for venture capital investment in the rapidly evolving healthcare industry. The company's dedication to accuracy and non-invasive testing solutions for complex diseases like cancer makes it a compelling prospect for investors seeking to support groundbreaking innovation in healthcare. Exciting times lie ahead for Early is Good as it seeks to make a meaningful impact on the future of healthcare.

Taxonomy: molecular diagnostics, biomarker detection, multi-omics, cancer detection, DNA testing, RNA testing, protein testing, metabolite testing, early disease detection, non-invasive testing, precision medicine

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• - 02 Nov 2022
Seed Round •••••• 1
Investor
02 Nov 2022

Early is Good Alternatives & Competitors

Early is Good vs
Pleno Inc.
Pleno Inc. United States

Targeted biological information at unprecedented scale, precision and performance.

Series B
39 employees
Biopharma, Biotechnology
Early is Good vs

Advancing global molecular testing with fully automated, multi-target gene detection solutions.

Biotechnology, Manufacturing
Early is Good vs
SMi Systems
SMi Systems United Kingdom

Transformational single-molecule detection and quantification for biomedical research and diagnostic...

Seed
19 employees
Biopharma, Manufacturing
Also compare with: Early is Good vs BillionToOne BillionToOne

FAQ About Early is Good

Ultra-Sensitive Multi-Omics Biomarker Detection To Transform The Future Healthcare
Early is Good was founded in 2021.
Early is Good is headquartered in Indianapolis, United States.
Early is Good operates in the following industries: Health Care.
Early is Good has approximately 5 employees.
Early is Good has completed 2 funding rounds, raising a total of $5.50M. The latest funding stage is Seed.
Top alternatives and competitors to Early is Good include Pleno Inc., LabTurbo Biotech, SMi Systems, Beacon Biomedical, BillionToOne. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Early is Good and Pleno Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Early is Good and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy